My guess is the original CMC problemswere likely far more complicated than we were told ... going back to PL's sugar coating of the issues and not disclosing they recieved the CRL. Complete incompetence...Now these new clowns have to finish it and who knows how capable they are. Again if you read the MD&A they do not provide clear language as to where they are with the submission and the FDA. They just say "we plan to submit", "we're working on" , COVID will delay blah blah ... Instead they could say, "we are ready to re-submit but need to complete a,b,c still ... but this quarter we have completed x,y and z ... they don't do much to instill confidence in them and so the stock will go down. Pretty amatuer ....